Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle, WA, USA.
Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA.
FEBS J. 2019 Jul;286(13):2434-2446. doi: 10.1111/febs.14866. Epub 2019 May 22.
A number of neurodegenerative diseases are characterized by deposition of abnormally phosphorylated tau or TDP-43 in disease-affected neurons. These diseases include Alzheimer's disease, frontotemporal lobar degeneration, and amyotrophic lateral sclerosis. No disease-modifying therapeutics is available to treat these disorders, and we have a limited understanding of the cellular and molecular factors integral to disease initiation or progression. Phosphorylated tau and TDP-43 are important markers of pathology in dementia disorders and directly contribute to tau- and TDP-43-related neurotoxicity and neurodegeneration. Here, we review the scope of tau and TDP-43 phosphorylation in neurodegenerative disease and discuss recent work demonstrating the kinases TTBK1 and TTBK2 phosphorylate both tau and TDP-43, promoting neurodegeneration.
许多神经退行性疾病的特征是在受疾病影响的神经元中沉积异常磷酸化的 tau 或 TDP-43。这些疾病包括阿尔茨海默病、额颞叶痴呆和肌萎缩侧索硬化症。目前尚无治疗这些疾病的方法,我们对疾病起始或进展所必需的细胞和分子因素的了解也很有限。磷酸化 tau 和 TDP-43 是痴呆症中病理的重要标志物,直接导致 tau 和 TDP-43 相关的神经毒性和神经退行性变。在这里,我们回顾了神经退行性疾病中 tau 和 TDP-43 磷酸化的范围,并讨论了最近的工作,证明激酶 TTBK1 和 TTBK2 磷酸化 tau 和 TDP-43,促进神经退行性变。